Fresenius | FRE - Cash And Equivalent



Fresenius reported EUR1.23B in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Akzo Nobel EUR 1.55B 47M Jun/2025
Alcon AG USD 1.41B 4M Jun/2025
AstraZeneca USD 7.06B 1.83B Jun/2025
BASF EUR 2.52B 203M Jun/2025
Bayer EUR 4.56B 542M Jun/2025
Beiersdorf EUR 1.17B 40M Jun/2025
DaVita Healthcare Partners USD 708.42M 269.64M Jun/2025
Demant 1.14B 30M Jun/2025
E.ON EUR 2.33B 1.06B Jun/2025
Essilor EUR 2.25B 86M Dec/2024
Fresenius EUR 1.23B 1.16B Jun/2025
Fresenius Medical Care EUR 1.72B 644.08M Jun/2025
Getinge SEK 2.96B 720M Dec/2024
Givaudan CHF 603M 3M Jun/2024
GlaxoSmithKline GBP 3.6B 865M Jun/2025
GN Store Nord DKK 787M 99M Mar/2025
GRIFOLS EUR 558.69M 194.13M Jun/2025
Hikma Pharmaceutical USD 188M 188M Dec/2024
Lonza CHF 1.11B 286M Dec/2024
Merck EUR 1.17B 161M Jun/2025
Novartis USD 6.66B 410M Jun/2025
Philips EUR 1.82B 629M Jun/2025
Roche Holding CHF 6.98B 2.15B Dec/2024
RWE EUR 2.76B 2.33B Mar/2025
Sanofi 15.36B 7.37B Jun/2025